Dual DAT/σ1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl) amino) propyl) piperazin-1-yl)-1-phenylpropan-1-ol

被引:15
作者
Cao, Jianjing [1 ]
Kopajtic, Theresa [2 ]
Katz, Jonathan L. [2 ]
Newman, Amy Hauck [1 ]
机构
[1] Natl Inst Drug Abuse, Med Chem Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA
[2] Natl Inst Drug Abuse, Psychobiol Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA
关键词
dopamine transport inhibitors; sigma receptors; cocaine; rimcazole; GBR; 12909;
D O I
10.1016/j.bmcl.2008.08.065
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Ester analogs of (+/-) 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol were synthesized and evaluated for binding at DAT, SERT, NET, and sigma 1 receptors, and compared to GBR 12909 and several known sigma 1 receptor ligands. Most of these compounds demonstrated high affinity (K(i) = 4.3-51 nM) and selectivity for the DAT among the monoamine transporters. S- and R-1-(4-(3(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-3-phenylpropan-2-ol were also prepared wherein modest enantioselectivity was demonstrated at the DAT. However, no enantioselectivity at sigma 1 receptors was observed and most of the ester analogs of the more active S- enantiomer showed comparable binding affinities at both DAT and sigma 1 receptors with a maximal 16-fold DAT/sigma 1 selectivity. Published by Elsevier Ltd.
引用
收藏
页码:5238 / 5241
页数:4
相关论文
共 19 条
[1]  
Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117
[2]   Dual probes for the dopamine transporter and σ1 receptors:: novel piperazinyl alkyl-bis(4′-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents [J].
Cao, JJ ;
Kulkarni, SS ;
Husbands, SM ;
Bowen, WD ;
Williams, W ;
Kopajtic, T ;
Katz, JL ;
George, C ;
Newman, AH .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (13) :2589-2598
[3]   [3-cis-3,5-dimethyl-(1-piperazinyl)alkyl]-bis-(4′-fluorophenyl)amine analogues as novel probes for the dopamine transporter [J].
Cao, JJ ;
Husbands, SM ;
Kopajtic, T ;
Katz, JL ;
Newman, AH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (24) :3169-3173
[4]  
Gilmore DL, 2004, CNS DRUG REV, V10, P1
[5]   Design and synthesis of promiscuous high-affinity monoamine transporter ligands: Unraveling transporter selectivity [J].
Greiner, E ;
Boos, TL ;
Prisinzano, TE ;
De Martino, MG ;
Zeglis, B ;
Dersch, CM ;
Marcus, J ;
Partilla, JS ;
Rothman, RB ;
Jacobson, AE ;
Rice, KC .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (05) :1766-1772
[6]   Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter [J].
Houlihan, WJ ;
Kelly, L ;
Pankuch, J ;
Koletar, J ;
Brand, L ;
Janowsky, A ;
Kopajtic, TA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (19) :4097-4109
[7]   Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: Role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters [J].
Hsin, Ling-Wei ;
Chang, Li-Te ;
Rothman, Richard B. ;
Dersch, Christina M. ;
Jacobson, Arthur E. ;
Rice, Kenner C. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) :2795-2806
[8]   Structure-activity relationships at the monoamine transporters and σ receptors for a novel series of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)-propyl]carbazole (rimcazole) analogues [J].
Husbands, SM ;
Izenwasser, S ;
Kopajtic, T ;
Bowen, WD ;
Vilner, BJ ;
Katz, JL ;
Newman, AH .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (21) :4446-4455
[9]   COCAINE AND SEVERAL SIGMA-RECEPTOR LIGANDS INHIBIT DOPAMINE UPTAKE IN RAT CAUDATE-PUTAMEN [J].
IZENWASSER, S ;
NEWMAN, AH ;
KATZ, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 243 (02) :201-205
[10]   Behavioral effects of rimcazole analogues alone and in combination with cocaine [J].
Katz, JL ;
Libby, TA ;
Kopajtic, T ;
Husbands, SM ;
Newman, AH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 468 (02) :109-119